CD133 has been considered a marker of cancer stem cells associated with several tumours, including in colorectal cancer10, 11, and increasing evidence12, 13 has demonstrated that these cells are associated with resistance to chemotherapy and radiotherapy. This evidence concerns the gene PROM1 and neoplasm.